Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Loading news article.

Purple Biotech Announces IM1240 Abstract Selected for Oral Presentation at the 38th EORTC-NCI-AACR Symposium | WAPE

Back All news

Newsfiscal.ai

Purple Biotech Announces IM1240 Abstract Selected for Oral Presentation at the 38th EORTC-NCI-AACR Symposium

Oct 30, 2026, 03:01 ET · Published

View source

Article summary

Purple Biotech's abstract for its lead tri-specific antibody, IM1240, has been accepted for an oral presentation at the upcoming 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

An excerpt from the original article.

Related companies

Purple Biotech Ltd. American Depositary SharesPPBTView stock

Purple Biotech Announces IM1240 Abstract Selected for Oral Presentation at the 38th EORTC-NCI-AACR Symposium

Article summary

Related companies

Analyzed by WAPE AI.

Comments —